Drug Trial Radar · NCT00687102
Cognition in the Study of Tamoxifen and Raloxifene
Last checked: Nov 20, 2026Latest source record: Sep 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,498
Actual
Start
Oct 2001
Primary completion
Mar 2008
Study completion Mar 2008
Sponsor
- Lead sponsor
- Wake Forest UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- May 30, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
Conditions
- Cognition
- Aging
Interventions
tamoxifenDrug
oral tamoxifen plus placebo daily for 5 years
raloxifeneDrug
oral raloxifene plus placebo daily for 5 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline on the the Benton Visual Retention Test Scores by Treatment GroupTime frame: Baseline and 3 Years
- Mean Change From Baseline on the the California Verbal Learning Test Scores by Treatment GroupTime frame: Baseline and 3 Years
Locations
134 sites in 2 countries. Site status is shown where the registry gives one.
CCOP Western Regional
Phoenix, Arizona
Arizona Cancer Center
Tucson, Arizona
Naval Hospital Camp Pendleton
Camp Pendleton, California
City of Hope National Medical Center
Duarte, California
Hematology Oncology Consultants
Duarte, California
Southern Nevada Cancer Research Foundation
Duarte, California
Virginia K. Crosson Cancer Center
Fullerton, California
Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California
Valley Tumor Medical Group
Lancaster, California
Kaiser Permanente Division of Research
Oakland, California
Ventura County Hematology-Oncology Specialists
Oxnard, California
North Valley Breast Clinic
Redding, California
Kaiser Permanente Oncology Research
San Diego, California
Naval Medical Center San Diego
San Diego, California
Cancer Foundation of Santa Barbara
Santa Barbara, California
Kaiser Permanente, Woodland Hills
Woodland Hills, California
Penrose Cancer Center
Colorado Springs, Colorado
Colorado Cancer Research Program
Denver, Colorado
St. Mary-Corwin Medical Center
Pueblo, Colorado
Hartford Hospital
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Lawrence & Memorial Hospital
New London, Connecticut
Christiana Care Health Services
Newark, Delaware
Washington Cancer Institute
Washington D.C., District of Columbia
Lakeland Regional Cancer Center
Lakeland, Florida
H. Lee Moffitt Cancer Center and Research Center
Tampa, Florida
Memorial Medical Center
Savannah, Georgia
University of Hawaii, Honolulu
Honolulu, Hawaii
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois
SwedishAmerican Hospital Regional Cancer Ctr
Rockford, Illinois
Carle Cancer Center
Urbana, Illinois
Center for Cancer Care at Goshen Health Systems
Goshen, Indiana
Community Hospital
Munster, Indiana
CCOP,Northern Indiana Research Consortium
South Bend, Indiana
Genesis Medical Center
Davenport, Iowa
Finely Hospital, Wendt Regional Cancer Center
Dubuque, Iowa
Via Christi Regional Medical Center
Wichita, Kansas
Ochsner Cancer Institute
New Orleans, Louisiana
The Harry and Jeanette Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland
Boston Medical Center
Boston, Massachusetts
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.